When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear directly from people whose lives have been transformed by NICE-recommended healthtech, including a hybrid closed loop system for type 1 diabetes, an implantable cardiac monitor to detect atrial fibrillation following a stroke, and a rapid genetic test that protects newborns from hearing loss caused by a common antibiotic. NICE's chief executive, Jonathan Benger, also shares our plans to support faster, fairer healthtech adoption across the NHS. Guests Jonathan Benger, NICE chief executive Ammaarah Ahmed and Aleix Rowlandson, who both benefit from a hybrid closed loop system to help manage their type 1 diabetes Peter Hooper, who was fitted with an implantable cardiac monitor to detect atrial fibrillation following his stroke Becky Ridley and baby Ginny, who benefitted from a rapid genetic test to help prevent hearing loss Caroline Knight who uses one-piece colostomy bags following bowel surgery Links Explore support for adopting or developing healthtech: https://www.nice.org.uk/what-nice-does/our-guidance/about-healthtech-guidance/nice-backing-the-healthtech-that-changes-lives NICE Advice service (for healthtech developers): www.nice.org.uk/niceadvice Subscribe to NICE News for Health and Social Care: www.nice.org.uk/nice-newsletters-and-alerts Subscribe to NICE News for Life Sciences: www.nice.org.uk/nice-newsletters-and-alerts Follow NICE on social media: search @NICEComms.

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. We're joined by Joanne McShane, an NHS health visitor who suffered from migraine for a decade; Dr Kay Kennis, GP with an extended role in Headache at Bradford Community Neurology Service; and Rob Music, chief executive at The Migraine Trust.

In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 2024. Developed collaboratively by the British Thoracic Society, NICE and the Scottish Intercollegiate Guidelines Network, the guideline has transformed how asthma is diagnosed and treated across the UK. We hear from frontline clinicians putting the guidance into practice and from those who helped develop it – including a patient who has lived with asthma for 65 years. Guests Maria Eurton – Respiratory Nurse Specialist, working across a primary care network of eight GP surgeries in Southampton Nazir Hussain – Specialist Respiratory Pharmacist, Dudley Group NHS Foundation Trust Phil Taverner – Lay Member, Guideline Development Committee (living with asthma for 65 years) Dr Sunil Gupta – GP and Clinical Advisor for NICE The Guideline Joint BTS/NICE/SIGN Asthma Guideline: http://www.nice.org.uk/guidance/ng245

We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Helen Knight, the deputy director of the centre for guidelines Eric Power, and Anastasia Chalkidou, the programme director of guidance delivery in HealthTech.

We're joined by representatives from the MHRA to discuss how NHS patients will be able to access medicines up to 6 months faster through an aligned MHRA and NICE pathway. Watch the webinar here: https://www.youtube.com/watch?v=FVBVYTUc2Q4

In this episode we learn how NICE is helping to deliver the government's 10 year health plan. Our guests are the senior responsible officers looking after the three NICE projects. They are: associate director for planning and operations Jenna Dilkes; deputy director for HealthTech Sarah Byron; anddeputy director for medicines evaluation Jac Bouvy.

In this episode, we discuss recent analysis showing significant disparities in SGLT-2 inhibitor prescriptions for people with type 2 diabetes in England. We also explore how our new draft recommendations for these medications could increase uptake with our three guests. They are: Dr Waqaar Shah, chair of the type 2 diabetes guideline committee; Dr Soon Song, consultant physician and diabetologist at Sheffield Teaching Hospitals NHS Foundation Trust; Dr Rahul Mohan, a GP and secretary of the Primary Care Diabetes Society. Learn more about: www.nice.org.uk/news/articles/wom…r-type-2-diabetes Read our draft guideline for type 2 diabetes medicines management: www.nice.org.uk/guidance/gid-ng10336/documents/450

Our Health Technology Assessment Innovation Laboratory (HTA Lab) was launched in June 2023 to test and develop creative solutions to complex problems in health technology assessment. Joining us to discuss its first 2 years of success are our guests: Jamie Elvidge, senior scientific adviser at NICE; Jack Turner, deputy director for medicines access at NHS England; and Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry.

NICE's prioritisation board has been in operation for just over 12 months. In this episode we review the first year and learn more about how decisions are made, incorporating the role of the patient voice. Our guests are Kay Nolan, head of prioritisation and surveillance at NICE, and Carole Pitkeathley, a lay member of NICE’s prioritisation board.

We're joined by health visitor Karen McLean and health psychologist Vivien Swanson, two members of the guideline committee, to discuss the changes made to the updated guideline to support nutrition and weight management in pregnancy, and nutrition in children up to 5 years. Find the guideline here: www.nice.org.uk/guidance/NG247

In this episode we’re going to be learning more about NICE's guidance for robotic assisted surgery. Our guests are Dr Anastasia Chalkidou, NICE’s HealthTech programme director. And John McGrath, consultant urologist at North Bristol NHS Trust, and chair of the NHSE Steering Committee for Robotic Assisted Surgery. Learn more about NICE's guidance for: Robotic-assisted surgery for soft tissue procedures: https://www.nice.org.uk/guidance/HTE21 Robotic-assisted surgery for orthopaedic procedures: https://www.nice.org.uk/guidance/HTE22